Wall Street brokerages forecast that MedEquities Realty Trust Inc. (NYSE:MRT) will report sales of $16.34 million for the current fiscal quarter, according to Zacks Investment Research. Three analysts have made estimates for MedEquities Realty Trust’s earnings, with estimates ranging from $15.97 million to $16.60 million. MedEquities Realty Trust posted sales of $14.01 million in the same quarter last year, which suggests a positive year over year growth rate of 16.6%. The business is scheduled to announce its next earnings results on Monday, February 26th.

According to Zacks, analysts expect that MedEquities Realty Trust will report full year sales of $16.34 million for the current fiscal year, with estimates ranging from $59.26 million to $61.40 million. For the next year, analysts anticipate that the business will report sales of $75.27 million per share, with estimates ranging from $74.30 million to $75.85 million. Zacks’ sales averages are an average based on a survey of sell-side research analysts that cover MedEquities Realty Trust.

A number of equities analysts have weighed in on the stock. B. Riley reaffirmed a “buy” rating on shares of MedEquities Realty Trust in a research note on Wednesday, November 1st. KeyCorp reaffirmed a “buy” rating and set a $13.00 target price on shares of MedEquities Realty Trust in a research note on Tuesday, September 26th. Cantor Fitzgerald began coverage on shares of MedEquities Realty Trust in a research report on Thursday, August 31st. They set an “overweight” rating and a $14.00 price target for the company. Capital One Financial Corporation reissued an “equal weight” rating on shares of MedEquities Realty Trust in a research report on Sunday, October 22nd. Finally, Zacks Investment Research raised shares of MedEquities Realty Trust from a “sell” rating to a “hold” rating and set a $12.00 price target for the company in a research report on Wednesday, November 15th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $12.83.

In other MedEquities Realty Trust news, Director Randy L. Churchey purchased 5,300 shares of the company’s stock in a transaction dated Monday, November 20th. The shares were acquired at an average price of $10.87 per share, for a total transaction of $57,611.00. Following the purchase, the director now directly owns 46,776 shares of the company’s stock, valued at approximately $508,455.12. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO John W. Mcroberts purchased 18,000 shares of the company’s stock in a transaction dated Friday, November 17th. The shares were acquired at an average price of $10.74 per share, for a total transaction of $193,320.00. The disclosure for this purchase can be found here. Insiders purchased 23,600 shares of company stock worth $254,129 in the last 90 days. 2.50% of the stock is currently owned by corporate insiders.

Institutional investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in shares of MedEquities Realty Trust by 10.8% during the 1st quarter. Vanguard Group Inc. now owns 1,095,341 shares of the financial services provider’s stock worth $12,278,000 after acquiring an additional 106,394 shares during the last quarter. Prudential Financial Inc. boosted its stake in shares of MedEquities Realty Trust by 2.1% during the 2nd quarter. Prudential Financial Inc. now owns 2,522,338 shares of the financial services provider’s stock worth $31,832,000 after acquiring an additional 52,622 shares during the last quarter. American Century Companies Inc. lifted its stake in shares of MedEquities Realty Trust by 10.3% during the 2nd quarter. American Century Companies Inc. now owns 1,551,947 shares of the financial services provider’s stock valued at $19,586,000 after buying an additional 145,427 shares in the last quarter. Foundry Partners LLC lifted its stake in shares of MedEquities Realty Trust by 9.0% during the 3rd quarter. Foundry Partners LLC now owns 526,740 shares of the financial services provider’s stock valued at $6,189,000 after buying an additional 43,350 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its stake in shares of MedEquities Realty Trust by 51.2% during the 2nd quarter. Bank of New York Mellon Corp now owns 107,443 shares of the financial services provider’s stock valued at $1,356,000 after buying an additional 36,394 shares in the last quarter. Institutional investors and hedge funds own 96.61% of the company’s stock.

MedEquities Realty Trust (NYSE:MRT) opened at $11.40 on Thursday. MedEquities Realty Trust has a one year low of $10.06 and a one year high of $13.06. The firm has a market cap of $356.62, a P/E ratio of 10.21 and a beta of -0.70.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, November 29th. Investors of record on Wednesday, November 15th will be issued a $0.21 dividend. This represents a $0.84 annualized dividend and a yield of 7.37%. The ex-dividend date is Tuesday, November 14th. MedEquities Realty Trust’s dividend payout ratio is currently 210.01%.

COPYRIGHT VIOLATION NOTICE: This piece was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/11/23/analysts-anticipate-medequities-realty-trust-inc-mrt-will-post-quarterly-sales-of-16-34-million.html.

About MedEquities Realty Trust

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Get a free copy of the Zacks research report on MedEquities Realty Trust (MRT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.